A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus
© Dombi et al.; licensee BioMed Central Ltd. 2012
Received: 14 December 2011
Accepted: 12 July 2012
Published: 8 August 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|14 Dec 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|8 Jan 2012||Author responded||Author comments - Theresa Dombi|
|Resubmission - Version 3|
|8 Jan 2012||Submitted||Manuscript version 3|
|22 Feb 2012||Reviewed||Reviewer Report - Matthias Maier|
|10 Mar 2012||Reviewed||Reviewer Report - Jonathan Micieli|
|12 Mar 2012||Reviewed||Reviewer Report - Michael Stewart|
|18 Jun 2012||Author responded||Author comments - Theresa Dombi|
|Resubmission - Version 4|
|18 Jun 2012||Submitted||Manuscript version 4|
|8 Jul 2012||Reviewed||Reviewer Report - Jonathan Micieli|
|9 Jul 2012||Reviewed||Reviewer Report - Michael Stewart|
|Resubmission - Version 5|
|Submitted||Manuscript version 5|
|12 Jul 2012||Editorially accepted|
|8 Aug 2012||Article published||10.1186/1471-2415-12-37|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.